The set of major clinical features of USP9X-female syndrome associated with de novo heterozygous gene deletion, nonsense and frameshift mutations involves developmental delay, ID, brain malformations and other congenital abnormalities impacting craniofacial development, and the heart, skeleton, skin and other organs10. The gene discussed is USP9X; the disease is Global developmental delay.